Appointment of WH Ireland as Joint Broker

RNS Number : 7567E

Microsaic Systems plc

03 March 2020

 

Microsaic Systems plc

("Microsaic" or the "Company")

Appointment of WH Ireland as Joint Broker

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce the appointment of WH Ireland Limited as Joint Broker with immediate effect, alongside N+1Singer as Nominated Adviser and Joint Broker.

Enquiries:

Microsaic Systems plc	[phone]
Glenn Tracey, CEO
Bevan Metcalf, FD
N+1 Singer (Nominated Adviser & Joint Broker)	[phone]
Aubrey Powell / George Tzimas (Corporate Finance)
Tom Salvesen (Corporate Broking)
WH Ireland Limited (Joint Broker)	[phone]
James Joyce
Jasper Berry
IFC Advisory Ltd (Financial PR)	[phone]
Graham Herring
Florence Chandler

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing, and have applications in environmental testing, chemical reaction monitoring, and academic teaching. The Company is working with a range of established global life science OEM partners, distributors and research organisations to co-develop and commercialise new solutions to improve productivity in the development of small molecule and novel biologic medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification and purity.

Microsaic's core products, the 4500 MiD®, and MiD®ProteinID are robust and compact MS systems, retaining the functionality of larger conventional MS systems, easier to use by non-specialists, consuming less energy and having lower running costs. For more information, please go to www.microsaic.com .

 

END

 

 

APPUPURUWUPUGMP